HCM vs PAHC

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

HCM

51.8
AI Score
VS
HCM Wins

PAHC

40.6
AI Score

Investment Advisor Scores

HCM

52score
Recommendation
HOLD

PAHC

41score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric HCM PAHC Winner
Forward P/E 18.0832 13.8313 PAHC
PEG Ratio 0 1.6791 Tie
Revenue Growth 0.2% 4.8% PAHC
Earnings Growth -96.5% 24.6% PAHC
Tradestie Score 51.8/100 40.6/100 HCM
Profit Margin 3.3% 6.6% PAHC
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

HCM 1M: -0.9% · 3M: +29.3% PAHC 1M: +16.7% · 3M: +17.0%

Current Technical Phase

HCM

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (8.5% over 20 days), RSI 54

RSI (14): 53.9 · Price: $14.24

PAHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.7% over 20 days), RSI 66

RSI (14): 65.6 · Price: $39.81

Fundamentals Snapshot

Metric HCM PAHC
Market Cap — —
Forward P/E 55.1 11.9
Trailing P/E 143.7 16.0
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin 0.1% 0.3%
Operating Margin 0.0% 0.1%
EPS 0.10 2.46
Dividend Yield — 0.01%

Frequently Asked Questions

Based on our detailed analysis, HCM is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.